Advances in liver transplantation: New strategies and current care expand access, enhance survival

Postgraduate Medicine

Volumn 115, Issue 5, 2004, Pages 73-85

  Tran, Tram T ^a,b   Nissen, Nicholas ^a,b   Poordad, F Fred ^a,b   Martin, Paul ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CALCIUM; CLONIDINE; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; DILTIAZEM; HEPATITIS B ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LABETALOL; LAMIVUDINE; METFORMIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; ORAL ANTIDIABETIC AGENT; PREDNISONE; RAPAMYCIN; RISEDRONIC ACID; TACROLIMUS; VERAPAMIL; VITAMIN D;

BONE NECROSIS; CADAVER DONOR; DIABETES MELLITUS; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERPLASIA; HEADACHE; HIRSUTISM; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LIVER DISEASE; LIVER TOXICITY; LIVER TRANSPLANTATION; LIVING DONOR; NEPHROTOXICITY; OSTEOPOROSIS; PRIMARY MEDICAL CARE; REVIEW; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREMOR;

EID: 2442561752     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2004.05.1514     Document Type: Review

References (26)

1. Starzl TE, Marchioro TL, VonKaulla KN, et al. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963;117:659-76
2. Seaberg EC, Belle SH, Beringer KC, et al. Liver transplantation in the United States from 1987-1998: updated results from the Pitt-UNOS liver transplant registry. In: Cecka JM, Terasaki PI, eds. Clinical transplants 1998. Vol 14. Los Angeles: UCLA Tissue Typing Laboratory, 1999: 17-37
3. US Scientific Registry. Richmond, Va: United Network for Organ Sharing (UNOS), 1999. Available at: http://www.unos.org. Accessed Feb 19, 2004
4. Bruix J. Treatment of hepatocellular carcinoma. Hepatology 1997;25(2):259-62
5. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334(11):693-9
6. O'Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97(2):439-45
7. Fattovich G, Giustina G, Degos F, et al Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997;112(2):651-5
8. Marino IR, Morelli F, Doria C, et al. Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era. Transplant Proc 1997;29(1-2):454-5
9. Lucey MR, Brown KA, Everson GT, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997;3(6):628-37
10. Watson CJ, Friend PJ, Jamieson NV, et al. Sirolimus: a potent new immunosuppressant for liver transplantation. Transplantation 1999; 67(4):505-9
11. Trotter JF. Sirolimus in liver transplantation. Transplant Proc 2003;35(3 Suppl):193-200S
12. US Department of Health and Human Services. Guide to clinical preventive services: report of the US Preventive Services Task Force. 2nd ed. Baltimore: Williams & Wilkins, 1996
13. Textor SC, Canzanello VJ, Taler SJ, et al. Hypertension after transplantation. Liver Transpl Surg 1995;1(5 Suppl 1):20-8
14. Todo S, Demetris AJ, Van Thiel D, et al. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991;13(4):619-26
15. Markowitz JS, Martin P, Conrad AJ, et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology 1998;28(2):585-9
16. Fukumoto T, Berg T, Ku Y, et al. Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions. Hepatology 1996;24(6):1351-4
17. Forman LM, Lewis JD, Berlin JA, et al. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122(4):889-96
18. Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;334(13): 815-20
19. Marsh JW, Dvorchik I, Subotin M, et al. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology 1997;26(2):444-50
20. De Vreede I, Steers JL, Burch PA, et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000; 6(3):309-16
21. Graziadei IW, Wiesner RH, Batts KP, et al. Recurrence of primary sclerosing cholarigitis following liver transplantation. Hepatology 1999; 29(4):1050-6
22. Hubscher SG, Elias E, Buckels JA, et al. Primary biliary cirrhosis: histological evidence of disease recurrence after liver transplantation. J Hepatol 1993;18(2):173-84
23. Milkiewicz P, Hubscher SG, Skiba G, et al. Recurrence of autoimmune hepatitis after liver transplantation. Transplantation 1999;68(2):253-6
24. Tran T, Changsri C, Peterson A, et al. Living donor liver transplantation: significant histologic abnormalities found on donor candidate biopsies. (Abstr) Gastroenterology 2003;124(4 Suppl 1):A17
25. Trotter JF, Wachs M, Trouillot T, et al. Evaluation of 100 patients for living donor liver transplantation: Liver Transpl 2000;6(3):290-5
26. Bucuvalas JC, Ryckman FC. The long- and short-term outcome of living-donor liver transplantation. J Pediatr 1999;134(3):259-61